- Home
- CVCO vs VKTX Comparison
CVCO vs VKTX Comparison
Compare CVCO & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVCO | VKTX |
|---|---|---|
| Founded | 1965 | 2012 |
| Country | United States | United States |
| Employees | 7000 | N/A |
| Industry | Homebuilding | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CVCO | VKTX |
|---|---|---|
| Price | $454.90 | $28.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $550.00 | $95.86 |
| AVG Volume (30 Days) | 108.0K | ★ 2.2M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.74 | N/A |
| EPS | ★ 18.55 | N/A |
| Revenue | ★ $2,142,713,000.00 | N/A |
| Revenue This Year | $14.66 | N/A |
| Revenue Next Year | $7.70 | N/A |
| P/E Ratio | $24.80 | ★ N/A |
| Revenue Growth | ★ 31.68 | N/A |
| 52 Week Low | $393.53 | $22.96 |
| 52 Week High | $713.01 | $43.15 |
Technical Indicators
Market Signals| Indicator | CVCO | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.36 | 32.93 |
| Support Level | $455.66 | $25.77 |
| Resistance Level | $604.08 | $36.20 |
| Average True Range (ATR) | 19.33 | 1.59 |
| MACD | -4.26 | -0.29 |
| Stochastic Oscillator | 17.79 | 5.88 |
Price Performance
Historical ComparisonAbout CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.